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Introduction {#sec005}
============

Asthma imposes a great health burden globally. It was estimated that about 300 million people were affected in 2011\[[@pone.0140443.ref001]\], and 250,000--345,000 people die from asthma each year \[[@pone.0140443.ref002]\]. From public health perspectives, more attention is needed to the etiology of asthma, especially in children, for whom the incidence of asthma was more than three times of that in adults \[[@pone.0140443.ref003]\].

Previous studies showed that maternal antibiotics exposure during pregnancy was associated with an increased risk of childhood asthma but the results were inconsistent. \[[@pone.0140443.ref004]--[@pone.0140443.ref009]\]. For example, Stensballe et al. reported that maternal exposure to different types of antibiotics in the third trimester was associated with elevated childhood asthma incidence \[[@pone.0140443.ref008]\], but McKeever et al. \[[@pone.0140443.ref007]\] failed to find any significant associations. Moreover, none of the previous studies examined the periconceptional window, which is a crucial period for embryo development \[[@pone.0140443.ref010]\]. Therefore, we conducted the present study to assess the associations between maternal exposure to different types of antibiotics before and during pregnancy and childhood asthma in the Collaborative Perinatal Project (CPP), a large prospective birth cohort study in the United States in 1959--1976.

Methods {#sec006}
=======

Study population {#sec007}
----------------

A detailed description of the study population and method has been provided elsewhere \[[@pone.0140443.ref011]\]. Briefly, 46,021 women with 56,990 pregnancies were enrolled at 12 sites in the United States from 1959 to 1965. These women were routinely interviewed during pregnancy and the newborns were followed up. Approximately 80 percent of the children were followed up to the age of seven to eight years. Physical examinations of neurological, neurosensory, cognitive development, general health and physical growth were taken at eight months, one, three, four, seven, and eight years of age in children \[[@pone.0140443.ref012]\]. Among 53,647 singleton births, 40,063 were followed until at least 7 years of age. The CPP was carried out by researchers who conducted the original study from 1959--1976.We excluded 156 children without a record of maternal periconceptional medication, leaving 39,907 children for the final analysis ([Fig 1](#pone.0140443.g001){ref-type="fig"}).

![Study population flow chart, Collaborative Perinatal Project, United States, 1959--1965.](pone.0140443.g001){#pone.0140443.g001}

Exposure to antibiotics {#sec008}
-----------------------

At the enrollment and each prenatal visit, women were asked regarding medication before and during pregnancy as previously described \[[@pone.0140443.ref013],[@pone.0140443.ref014]\]. The name of medicine and the time of medicine exposure were recorded. The maternal antibiotic exposure was defined as the mother taking antibiotics by oral or injection during 4 weeks prior to the last menstrual period (LMP)or at any month during pregnancy. We separated the exposure windows into periconception (within 28 days prior to LMP), 1^st^ (day 1 after LMP to day 91), 2^nd^ (day 92 to 189), and 3^rd^ trimesters (day 190 to delivery).

Diagnosis of asthma {#sec009}
-------------------

Medical records of each child from birth through the age of 7 years were reviewed by pediatricians. The diagnosis of asthma was made as "suspected", "definite," or "history only". The present study used "definite" asthma by 7 years of age as the outcome. The "definite asthma" of children was identified by the relevant code from the World Health Organization International Classification of Diseases (ICD) in the revisions, including 241 in the 7th revision in 1958, and 493 in the 8th revision in 1968.This classification scheme was consistent with previous studies using the data from CPP \[[@pone.0140443.ref015],[@pone.0140443.ref016]\].

Covariates {#sec010}
----------

The following prenatal factors were included as potential confounders for the associations between maternal exposure to antibiotics and childhood asthma \[[@pone.0140443.ref017]\], maternal age at delivery (\<20, 20--29, 30--39, or≥40 years), married at pregnancy (no/yes); race (white, black, or other); educational level (\<9, 10--12, or \>12 years); number of previous births (0, 1, or≥2); smoking during pregnancy (0, 1--9, or≥10 cigarettes per day), maternal asthma history (no/yes), and maternal drug allergy history (no/yes). If a covariant changed the association between exposure and outcome by 10% or more in a logistic regression model, we considered this variable as a potential confounder and controlled for it.

Statistical analysis {#sec011}
--------------------

Chi-square test was used to assess the differences of maternal and children's characteristics at baseline in children with and without asthma. Because some women gave more than one birth in the CPP, the associations between maternal exposure to antibiotics and the risk of childhood asthma were explored with multilevel multiple logistic regression models, accounting for the correlation between births from the same mother. The results were presented as odds ratios (OR) and 95% confidence intervals (CI). All statistical analysis was performed using SAS 9.2 (SAS Institute, Inc., Cary,North Carolina).

Results {#sec012}
=======

The prevalence of asthma was 5.5% (2,201/39,907) in this population. Baseline characteristics of these children are shown by asthma status in [Table 1](#pone.0140443.t001){ref-type="table"}. No significant differences were observed in maternal age at pregnancy, maternal educational level, maternal smoking during pregnancy, and delivery mode between asthma and non-asthma groups. However, the asthmatic children had a higher proportion of unmarried, asthmatic mothers, mothers with drug allergy history, male infants and black race (all p\<0.05).

10.1371/journal.pone.0140443.t001

###### Maternal and Child Characteristics by Asthma Status in the Collaborative Perinatal Project, United States, 1959--1965.

![](pone.0140443.t001){#pone.0140443.t001g}

  Characteristic                  Nonasthma (n = 37706)   Asthma (n = 2201)   P value [^a^](#t001fn001){ref-type="table-fn"}          
  ------------------------------- ----------------------- ------------------- ------------------------------------------------ ------ ---------
  Maternal race                                                                                                                       \<0.001
   White                          17598                   46.7                849                                              38.6   
   Black                          18587                   49.3                1222                                             55.5   
   Other                          1507                    4.0                 130                                              5.9    
  Maternal age, (years)                                                                                                               0.370
   \<20                           8830                    23.4                535                                              24.3   
   20--29                         21348                   56.6                1204                                             54.7   
   30--39                         6837                    18.1                420                                              19.1   
   ≥40                            691                     1.8                 42                                               1.9    
  Married at pregnancy            29202                   77.4                1644                                             74.7   0.003
  Maternal education (years)                                                                                                          0.180
   ≤9                             10469                   27.8                652                                              29.6   
   10--12                         22403                   59.4                1276                                             58.0   
   \>12                           4266                    11.3                243                                              11.0   
  Smoking during pregnancy                                                                                                            0.187
   Nonsmoker (0 cig./day)         19967                   53.0                1146                                             52.1   
   Light smoker (1--9 cig./day)   6576                    17.4                419                                              19.0   
   Heavy smoker (≥10 cig./day)    10872                   28.3                628                                              28.5   
  Maternal asthma                 844                     2.2                 152                                              6.9    \<0.001
  Maternal drug allergy           2072                    5.5                 159                                              7.2    0.001
  Parity                                                                                                                              0.275
   0                              738                     2.0                 52                                               2.4    
   1                              8390                    22.3                492                                              22.4   
   ≥2                             18293                   48.5                1031                                             46.8   
  Mode of delivery                                                                                                                    0.425
   Vaginal                        34710                   92.1                2015                                             91.5   
   Assisted vaginal               843                     2.2                 58                                               2.6    
   Cesarean                       2057                    5.5                 125                                              5.7    
  Birthweight, g                                                                                                                      0.024
   \<2500                         3476                    9.2                 244                                              11.1   
   2500--2999                     9313                    24.7                555                                              25.2   
   3000--3499                     15028                   39.9                869                                              39.5   
   3500--3999                     7841                    20.8                420                                              19.1   
   ≥4000                          2034                    5.4                 113                                              5.1    
  Preterm birth(\<37 weeks)       5678                    15.1                408                                              18.5   \<0.001
  Male sex                        18809                   49.9                1382                                             62.8   \<0.001
  5-minute Apgar score 0--6       1349                    3.6                 88                                               4.0    0.303

^a^: P values were determined by χ^2^ test.

A total of 10,534 (26.4%) mothers were treated with antibiotics one month prior to LMP or during pregnancy. The vast majority of them used one type of antibiotics (22.5%). Penicillin was the most commonly used antibiotic (15.6% of all mothers) followed by sulfonamides and trimethoprim (10.1% of all mothers). Most mothers received antibiotic treatment in the second (12.8% of all mothers) or third (12.7% of all mothers) trimesters.

[Table 2](#pone.0140443.t002){ref-type="table"} shows the associations between maternal exposure to various antibiotics before and during pregnancy and asthma in the offspring. Maternal use of penicillin or chloramphenicol was associated with a significantly increased risk of childhood asthma after adjusting for potential confounders (adjusted OR = 1.21 \[95% CI1.08--1.36\] for penicillins; adjusted OR = 1.72 \[95% CI1.14--2.59\] for chloramphenicols). We further separated the results by the time of medication. Penicillins or chloramphenicols use in first trimester was significantly associated with childhood asthma (adjusted OR = 1.09 \[1.04--1.13\] and1.23 \[1.01--1.51\], respectively).When we further controlled for low birthweight and preterm birth as potential confounders in the multilevel logistic regression models, the results didn't change.

10.1371/journal.pone.0140443.t002

###### Adjusted and unadjusted risk of childhood asthma exposed to maternal antibiotic use during 4 weeks before LMP and pregnancy and followed to 7 years of age.

![](pone.0140443.t002){#pone.0140443.t002g}

  Antibiotics exposure                Number of mothers using antibiotics   Unadjusted estimates                     Adjusted estimates [^a^](#t002fn001){ref-type="table-fn"}                                                                                               
  ----------------------------------- ------------------------------------- ---------------------------------------- ----------------------------------------------------------- --------- ---------------------------------------- ---------------------------------------- ---------
  **Penicillins**                                                                                                                                                                                                                                                            
  total                               6208                                  1.25                                     1.11--1.40                                                  \<0.001   1.21                                     1.09--1.36                               0.001
  4 weeks before LMP                  751                                   1.07                                     0.99--1.15                                                  0.069     1.06                                     0.99--1.14                               0.100
  1st trimester                       2305                                  1.09                                     1.05--1.14                                                  \<0.001   1.09                                     1.04--1.13                               \<0.001
  2nd trimester                       2619                                  1.03                                     0.99--1.07                                                  0.209     1.02                                     0.98--1.06                               0.376
  3rd trimester                       1899                                  1.01                                     0.97--1.07                                                  0.583     1.01                                     0.96--1.07                               0.606
  **Sulfonamides and trimethoprim**                                                                                                                                                                                                                                          
  total                               4044                                  1.03                                     0.89--1.19                                                  0.688     0.98                                     0.85--1.13                               0.756
  4 weeks before LMP                  165                                   1.08                                     0.93--1.25                                                  0.339     1.07                                     0.92--1.25                               0.354
  1st trimester                       676                                   1.03                                     0.95--1.11                                                  0.529     1.02                                     0.94--1.10                               0.707
  2nd trimester                       1687                                  1.05                                     1.00--1.11                                                  0.044     1.04                                     0.99--1.09                               0.131
  3rd trimester                       2264                                  0.98                                     0.94--1.03                                                  0.459     0.97                                     0.92--1.02                               0.184
  **Chloramphenicols**                                                                                                                                                                                                                                                       
  total                               290                                   1.77                                     1.18--2.65                                                  0.006     1.72                                     1.14--2.59                               0.009
  4 weeks before LMP                  15                                    1.05                                     0.63--1.76                                                  0.845     1.05                                     0.62--1.76                               0.857
  1st trimester                       58                                    1.24                                     1.01--1.52                                                  0.038     1.23                                     1.01--1.51                               0.044
  2nd trimester                       128                                   1.16                                     0.99--1.34                                                  0.062     1.13                                     0.97--1.32                               0.107
  3rd trimester                       125                                   1.11                                     0.94--1.30                                                  0.232     1.11                                     0.94--1.31                               0.223
  **Tetracycline**                                                                                                                                                                                                                                                           
  total                               549                                   1.25                                     0.99--1.57                                                  0.067     1.20                                     0.95--1.52                               0.133
  4 weeks before LMP                  19                                    1.19                                     0.82--1.73                                                  0.354     1.21                                     0.83--1.76                               0.314
  1st trimester                       77                                    0.82                                     0.58--1.17                                                  0.281     0.84                                     0.59--1.20                               0.341
  2nd trimester                       227                                   1.03                                     0.90--1.18                                                  0.660     1.02                                     0.89--1.17                               0.814
  3rd trimester                       260                                   1.09                                     0.97--1.23                                                  0.130     1.07                                     0.95--1.20                               0.280
  **Nitrofurans**                                                                                                                                                                                                                                                            
  total                               385                                   1.21                                     0.84--1.73                                                  0.307     1.12                                     0.78--1.61                               0.552
  4 weeks before LMP                  9                                     [^b^](#t002fn002){ref-type="table-fn"}   [^b^](#t002fn002){ref-type="table-fn"}                                [^b^](#t002fn002){ref-type="table-fn"}   [^b^](#t002fn002){ref-type="table-fn"}   
  1st trimester                       29                                    1.18                                     0.87--1.61                                                  0.278     1.21                                     0.89--1.65                               0.220
  2nd trimester                       142                                   1.01                                     0.84--1.21                                                  0.948     0.98                                     0.81--1.17                               0.789
  3rd trimester                       248                                   1.04                                     0.91--1.18                                                  0.550     1.02                                     0.90--1.16                               0.779
  **Otherantibiotics**                                                                                                                                                                                                                                                       
  total                               727                                   1.26                                     1.00--1.59                                                  0.047     1.21                                     0.96--1.53                               0.105
  4 weeks before LMP                  90                                    1.00                                     0.80--1.26                                                  0.973     0.99                                     0.79--1.24                               0.915
  1st trimester                       228                                   1.03                                     0.90--1.18                                                  0.669     1.01                                     0.88--1.16                               0.930
  2nd trimester                       302                                   0.97                                     0.85--1.11                                                  0.683     0.97                                     0.85--1.11                               0.695
  3rd trimester                       280                                   1.01                                     0.89--1.15                                                  0.867     1.01                                     0.89--1.15                               0.883

^a^: adjusted for maternal age at delivery, marital status at pregnancy, race, educational level, parity, smoking during pregnancy, maternal asthma history, and maternal history of drug allergy.

^b^: The precise value can't becalculated, because the sample size was too small to analyze.

LMP: last menstrual period

A sensitivity analysis was conducted by excluding women who reported having exposed to two or more types of antibiotics before or during pregnancy. The results remained virtually the same (not shown). When we stratified the results by the time of medication, again the results were very similar ([S1 Table](#pone.0140443.s001){ref-type="supplementary-material"}).

Discussion {#sec013}
==========

In this prospective cohort study, we found that use of penicillins or chloramphenicols during early pregnancy was associated with an increased risk of asthma in offspring after controlling for potential confounders. These findings suggest that early life exposure to certain antibiotics might increase the risk of childhood asthma.

Our finding is consistent with two Danish longitudinal cohort studies, in which if mothers used antibiotics at any time during pregnancy, the children had an increased risk of asthma hospitalization (hazard ratio 1.17 \[1.00--1.36\]), and inhaled corticosteroids (1.18 \[1.10--1.27\]) \[[@pone.0140443.ref008]\]. However, a recent Swedish study using sibling analysis suggested that previous positive findings may have been due to confounding by indication or uncontrolled genetic and environmental confounders \[[@pone.0140443.ref018]\]. Although the sibling analysis may have adjusted residual familial factors better, the exposure combined all types of antibiotics in that study \[[@pone.0140443.ref018]\]. Our study showed when all antibiotics were combined, the significant association found in penicillin was reduced, indicating that the association may be antibiotic-specific.

Some old antibiotics are no longer being used in contemporary practice. However, our findings raised several questions that may still have important clinical and pharmacodevelopmental implications. In pregnancy, different antibiotics have specific effect on changing maternal microbiota \[[@pone.0140443.ref019],[@pone.0140443.ref020]\]. The latter could be transmitted to the fetus not only during delivery \[[@pone.0140443.ref021]\], but during pregnancy as well \[[@pone.0140443.ref021]--[@pone.0140443.ref023]\]. The placental microbiome produces metabolic and immune factors, and generates a balanced mucosal immune system \[[@pone.0140443.ref024]\]. When microbial exposure of fetus was disturbed, the risk of atopic immune responses and asthma is increased \[[@pone.0140443.ref025]\]. Thus, we speculate that the effect on asthma risk may be related to the antibacterial spectrum of penicillins or chloramphenicols, both of which target gram positive bacteria. Detailed types of microbiota and their explicit mechanism need to be further elucidated in future epidemiologic studies and *in vitro* experiments.

Our study also found that the early pregnancy may be a sensitive window for the exposure to penicillins or chloramphenicols. The early pregnancy is an important time for fetal immune development \[[@pone.0140443.ref026]\]. Even at the 12 weeks of gestation, T cell has begun to develop \[[@pone.0140443.ref026]\]. Furthermore, the sensitive window may also depend on the type of antibiotics. More research is needed. Since in CPP data, women were asked about their health condition 4 weeks before LMP, including medication, we used 4-week timeframe and were unable to restrict our analysis to exposure periods closer to the time of actual conception.

We acknowledge that the diagnostic criteria for asthma may have changed since 1960s. The asthma diagnosis then was based on notion that asthma is "a disease of the respiratory passages characterized by dyspnea of an obstructive type which is predominantly expiratory, reversible at least partially, and of varying severity and duration" \[[@pone.0140443.ref027]\]. Even today, asthma diagnosis in young children is still made based largely on symptom patterns and on a careful clinical assessment of family history and physical findings according to the Global Initiative for Asthma works \[[@pone.0140443.ref028],[@pone.0140443.ref029]\]. This is due to the fact that lung function measures in children may not be reliable, even in children of 7 years \[[@pone.0140443.ref030]\]. In our study, we included only "definite asthma" confirmed by pediatricians and excluded suspected asthma. The prevalence of asthma was 5.5% at that time, suggesting that misclassification of asthma may not be a serious issue in our study.

It may be questioned whether the association between maternal antibiotic use before and during pregnancy and childhood asthma was due to confounding by indication or genetics, i.e., women who used antibiotics tended to have an elevated risk of asthma-related diseases. This tendency may pass down to their children. Thus, it would be the genetic susceptibility to asthma rather than antibiotic use *per se* that has caused this association \[[@pone.0140443.ref018]\]. Unfortunately, CPP did not collect information on indication for maternal antibiotic use. However, only maternal urinary tract infections during pregnancy were found to increase the risk of asthma in children in previous studies \[[@pone.0140443.ref031]\], whereas penicillins or chloramphenicols weren't indicated to use in urinary tract infections. Therefore, the association between maternal exposure to penicillins or chloramphenicols and childhood asthma may not be confounded by maternal infections that led to penicillins or chloramphenicols use. Moreover, our study shows that even after we adjusted for history of maternal asthma and allergy, exposure to certain drugs, namely penicillins and chloramphenicols, during early pregnancy was associated with child asthma.

In addition, over 11,000 children were lost to follow-up and, therefore, often did not have asthma diagnosis. But the prevalence of antibiotic exposure or asthma history of mothers was similar between those lost and followed-up. For example, the prevalence of antibiotic exposure was 26.4% vs 27.7% for mothers included vs mothers with loss-to-follow-up, respectively. Likewise, the prevalence of maternal asthma history was 4.7% vs 5.3%, respectively. These differences appeared small and were unlikely to bias the results substantially.

In conclusion, maternal exposure to penicillins or chloramphenicols during pregnancy is associated with childhood asthma by 7 years of age. Early pregnancy may be a sensitive window. Our findings not only confirmed previous reports that maternal exposure to antibiotics enhances the risk of childhood asthma, but also showed that this association may be antibiotic-specific.
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